The impact of a Hepatitis B birth dose vaccine on HBV immunogenicity and incidence in children in the DRC
乙型肝炎出生剂量疫苗对刚果民主共和国儿童乙型肝炎免疫原性和发病率的影响
基本信息
- 批准号:10671623
- 负责人:
- 金额:$ 4.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-08-01 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AdoptedAfrica South of the SaharaAfricanAgeAge MonthsAsiaBirthBloodCategoriesCause of DeathCessation of lifeChildChildbirthChildhoodChronic HepatitisCommunicable DiseasesCommunitiesDataData AnalysesDemocratic Republic of the CongoDevelopmentDiseaseDoctor of PhilosophyDoseDrynessEffectivenessEpidemiologic MethodsEpidemiologyFellowshipFutureGovernmentGrantHIVHIV/AIDSHealthHepatitis BHepatitis B AntibodiesHepatitis B IncidenceHepatitis B InfectionHepatitis B PrevalenceHepatitis B TransmissionHepatitis B VaccinesHorizontal Disease TransmissionHourHouseholdImmunityImmunologyIncidenceInfantInfant HealthInfectionInfectious Disease EpidemiologyInterventionIntervention StudiesKnowledgeMalariaMeasuresMentorsModelingMorbidity - disease rateMothersNewborn InfantNorth CarolinaPhysiciansPoliciesProvinceRandomizedResearchScheduleScientistSeriesSpottingsTrainingTuberculosisUniversitiesVaccinatedVaccinesVertical TransmissionViral hepatitisburden of illnesscareercohortepidemiological modelglobal healthimmunogenicityimprovedinfant infectioninterestintervention programmarkov modelmathematical modelmembermortalitypreventprotective efficacysecondary analysisskillstranslational studyvaccination schedulevaccinology
项目摘要
PROJECT SUMMARY
Over the past few decades, viral hepatitis has become a leading cause of death globally, causing more deaths
each year than malaria, HIV/AIDS, or tuberculosis. When considering Hepatitis B (HBV), this large burden of
disease is largely driven by childhood infections, as 90% of infants infected with HBV will develop chronic
hepatitis with lifelong sequelae. Childhood HBV infection occurs through vertical transmission (from mothers to
children during childbirth) and through horizontal transmission (between members of the same household or
community). In sub-Saharan Africa (SSA), where HBV remains endemic, children are vaccinated against HBV
at 6, 10, and 14 weeks of age. This schedule does not protect against vertical transmission, and an estimated
1% of newborns (367,250 infants) in SSA continue to be infected with HBV at birth each year. Administration of
the monovalent HBV vaccine at birth has been shown to have up to 95% protective efficacy against vertical
transmission in the WHO Western Pacific region. However, few studies have been conducted to
characterize the potential impact of providing a birth dose of HBV vaccine in sub-Saharan African
settings. Our partners for this project, the Ministry of Health in the Democratic Republic of the Congo (DRC)
are particularly interested in understanding whether to adopt a national HBV birth dose intervention.
This translational study will provide estimates of the effectiveness and impact of a 4-dose HBV vaccine series
(including a birth dose) in the DRC. The proposed research will utilize previously collected data and dried blood
spots from two trials in Kinshasa Province, DRC: the Birth Dose Immunogenicity Study and the Continuous
Quality Improvement Study. Using advanced epidemiological methods and mathematical modeling, this
proposal aims to 1) compare the proportion of infants who achieve protective immunity to HBV at 12
months of age by vaccine dose series and mothers' HBV and HIV status and 2) model the impact of
adopting a national 4-dose HBV vaccine series, including the birth dose, on the incidence of HBV in
children under 5 in the DRC. The results will provide valuable estimates of the immunogenicity and potential
impact of an HBV birth dose that will inform vaccine policy in the DRC and greater sub-Saharan African region.
Through the completion of these research aims, the trainee will gain a unique set of skills in advanced
epidemiologic methods, mathematical modeling, and vaccine intervention research. Expert mentors in
vaccinology, immunology, modeling, and epidemiology will support the trainee's successful completion of the
proposed research, associated training plan, and MD/PhD degree at the University of North Carolina at Chapel
Hill. This F30 fellowship will aid the applicant's development as a future interdisciplinary physician-scientist
practicing at the intersection of infectious disease, infant health, and interventional epidemiology.
项目摘要
在过去的几十年里,病毒性肝炎已成为全球死亡的主要原因,造成更多的死亡
比疟疾、艾滋病和肺结核都多。当考虑到B肝炎(HBV),这种巨大的负担,
这种疾病主要是由儿童感染引起的,因为90%感染HBV的婴儿会发展成慢性乙型肝炎。
有终身后遗症肝炎。儿童HBV感染通过垂直传播(从母亲到
分娩期间的子女)和横向传播(同一家庭成员之间或
社区)。在HBV仍然流行的撒哈拉以南非洲(SSA),
在6、10和14周龄时。这一时间表并不能防止垂直传播,
SSA每年有1%的新生儿(367,250名婴儿)在出生时继续感染HBV。总局
在出生时接种单价HBV疫苗已显示出对垂直感染具有高达95%的保护效力,
世卫组织西太平洋区域的传播。然而,很少有研究表明,
描述在撒哈拉以南非洲地区提供出生剂量HBV疫苗的潜在影响
设置.本项目的合作伙伴是刚果民主共和国卫生部
特别感兴趣的是了解是否采取国家HBV出生剂量干预。
这项转化研究将提供4剂HBV疫苗系列的有效性和影响的估计
(包括出生剂量)。拟议中的研究将利用以前收集的数据和干血
来自刚果民主共和国金沙萨省两项试验的斑点:出生剂量免疫原性研究和连续免疫原性研究。
质量改进研究。利用先进的流行病学方法和数学建模,
该提案旨在1)比较12岁时获得HBV保护性免疫的婴儿比例,
月龄的疫苗剂量系列和母亲的HBV和HIV状态和2)模型的影响,
采用国家4剂乙肝疫苗系列,包括出生剂量,
刚果民主共和国5岁以下儿童。结果将提供有价值的估计免疫原性和潜在的
HBV出生剂量的影响,将告知刚果民主共和国和撒哈拉以南非洲地区的疫苗政策。
通过完成这些研究目标,学员将获得一套独特的技能,
流行病学方法、数学建模和疫苗干预研究。专家导师在
疫苗学、免疫学、建模和流行病学将支持受训者成功完成
在北卡罗来纳州查珀尔大学进行研究,制定相关的培训计划,并获得医学博士/博士学位
之丘这个F30奖学金将帮助申请人的发展,作为一个未来的跨学科的物理学家,科学家
在传染病、婴儿健康和干预流行病学的交叉点执业。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Low knowledge about hepatitis B prevention among pregnant women in Kinshasa, Democratic Republic of Congo.
- DOI:10.1371/journal.pgph.0000450
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Samantha Tulenko其他文献
Samantha Tulenko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Samantha Tulenko', 18)}}的其他基金
The impact of a Hepatitis B birth dose vaccine on HBV immunogenicity and incidence in children in the DRC
乙型肝炎出生剂量疫苗对刚果民主共和国儿童乙型肝炎免疫原性和发病率的影响
- 批准号:
10312874 - 财政年份:2021
- 资助金额:
$ 4.77万 - 项目类别:
The impact of a Hepatitis B birth dose vaccine on HBV immunogenicity and incidence in children in the DRC
乙型肝炎出生剂量疫苗对刚果民主共和国儿童乙型肝炎免疫原性和发病率的影响
- 批准号:
10455457 - 财政年份:2021
- 资助金额:
$ 4.77万 - 项目类别:
相似海外基金
ESE: Collaborative Research: Climate Change and Variability and Armed Conflicts in Africa South of the Sahara
ESE:合作研究:撒哈拉以南非洲的气候变化和变异性以及武装冲突
- 批准号:
0964515 - 财政年份:2010
- 资助金额:
$ 4.77万 - 项目类别:
Standard Grant
Network Dynamics, Sexual Behaviour, and HIV Among University Students in Africa South of the Sahara
撒哈拉以南非洲大学生的网络动态、性行为和艾滋病毒
- 批准号:
178094 - 财政年份:2008
- 资助金额:
$ 4.77万 - 项目类别:
Studentship Programs
Synopsis of Ichneumoniae of Africa, South of the Sahara
撒哈拉以南非洲的姬蜂病简介
- 批准号:
66B2956 - 财政年份:1966
- 资助金额:
$ 4.77万 - 项目类别:
To Attend Synopsis of Ichneumoninae of Africa, South of the Sahara
参加撒哈拉以南非洲的姬蜂亚科概要
- 批准号:
65B2956 - 财政年份:1965
- 资助金额:
$ 4.77万 - 项目类别: